Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar;74(3):244-52.
doi: 10.1590/0004-282X20160038.

Current concepts in the treatment of hereditary ataxias

Affiliations
Review

Current concepts in the treatment of hereditary ataxias

Pedro Braga Neto et al. Arq Neuropsiquiatr. 2016 Mar.

Abstract

Hereditary ataxias (HA) represents an extensive group of clinically and genetically heterogeneous neurodegenerative diseases, characterized by progressive ataxia combined with extra-cerebellar and multi-systemic involvements, including peripheral neuropathy, pyramidal signs, movement disorders, seizures, and cognitive dysfunction. There is no effective treatment for HA, and management remains supportive and symptomatic. In this review, we will focus on the symptomatic treatment of the main autosomal recessive ataxias, autosomal dominant ataxias, X-linked cerebellar ataxias and mitochondrial ataxias. We describe management for different clinical symptoms, mechanism-based approaches, rehabilitation therapy, disease modifying therapy, future clinical trials and perspectives, genetic counseling and preimplantation genetic diagnosis.

As ataxias hereditârias represent um grupo complexo de doenças neurodegenerativas, e se caracterizam por ataxia cerebelar progressiva, associada a sinais e sintomas extra-cerebelares e sistêmicos, os quais incluem: neuropatia periférica, sinais piramidais, distúrbios do movimento, convulsões e disfunção cognitiva. Não existe um tratamento efetivo para a cura das ataxias hereditârias. Até o momento os tratamentos disponiveis sâo apenas sintomâticos. Nesta revisâo vamos abordar tratamento sintomâtico das principals ataxias autossômicas recessivas, ataxias autossômicas dominantes, ataxias ligadas ao X e ataxias mitocondriais. Descrevemos os diferentes sintomas, abordagens terapêuticas baseadas no mecanismo fisiopatolôgico, terapia de reabilitaçâo, terapia modificadora da doença, futures ensaios clinicos, perspectivas, niveis de evidência, aconselhamento genético e diagnôstico genético pré-implantacional.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: There is no conflict of interest to declare.

References

    1. Teive HA, Ashizawa T. Primary and secondary ataxias. Curr opin Neurol. 2015:28:413–22. doi: 10.1097/WC0.0000000000000227 - DOI - PMC - PubMed
    1. Anhelm M, Tranchant C, Koenig M.The autosomal recessive cerebellar ataxias. N Engl .J Med 2012:366(7):636–46. doi: 10.1056/NEdMra1006610 - DOI - PubMed
    1. Fogel EL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol. 2007;6(3):245–57. doi: 10.1016/S1474-4422(07)70054-6 - DOI - PubMed
    1. Abrahao A, Pedroso JL, Braga-Neto R Bor-Seng-Shu E, Carvalho Aguiar P Barsottmi OG. Milestones in Friedreich ataxia: more than a century and still learning. Neurogenetics. 2015:16(3): 151–60. doi: 10.1007/s10048-015-0439-z - DOI - PubMed
    1. Hentati F, El-Euch GB ouhlal Y. Amouri R. Ataxia with vitamin E deficiency and abetalipoproteinemia. Handb Clin Neurol. 2012:103:295–305. doi:10.1016/B978-0-444-51892-7.00018-8 - DOI - PubMed

MeSH terms